Department of Chemistry, Hafiz Hayat Campus, University of Gujrat, Gujrat, Pakistan.
Department of Chemistry, Hafiz Hayat Campus, University of Gujrat, Gujrat, Pakistan.
Comput Biol Chem. 2023 Jun;104:107880. doi: 10.1016/j.compbiolchem.2023.107880. Epub 2023 May 8.
Molecular modeling strategy was adopted to check the biological potential of the imine based molecules against free radical, acetylcholine esterase and butyrylcholine esterase. Three Schiff based compounds as (E)-2-(((4-bromophenyl)imino)methyl)-4-methylphenol (1), (E)-2-(((3-fluorophenyl)imino)methyl)-4-methylphenol (2) and (2E,2E)-2-(2-(2-hydroxy-5-methylbenzylidene)hydrazono)-1,2-diphenylethanone (3) were synthesized with high yield. The synthesized compounds were characterized with the help of modern techniques such as UV, FTIR and NMR while exact structure was depicted with Single Crystal X-Ray diffraction technique which disclosed that compound 1 is orthorhombic, while 2 and 3 are monoclinic. A hybrid functional (B3LYP) method with general basis set of 6-31 G(d,p) were applied to optimize synthesized Schiff bases. The contribution of in-between molecular contacts within a crystalline assembly of compounds were studied using Hirshfeld surface analysis (HS). In order to check the ability of the synthesized compounds toward free radical and enzyme inhibition, in vitro models were used to assess the radical scavenging and enzyme inhibition potential which depicted that compound 3 showed highest potential (57.43 ± 1.0%; DPPH, 75.09 ± 1.0%; AChE and 64.47 ± 1.0%; BChE). The ADMET assessments suggested the drug like properties of the synthesized compounds. It was concluded from results (in vitro and in silico) that synthesized compound have ability to cure the disorder related to free radical and enzyme inhibition. Compound 3 was shown to be the most active compared to other compounds.
采用分子建模策略来检查基于亚胺的分子对自由基、乙酰胆碱酯酶和丁酰胆碱酯酶的生物潜力。合成了三种席夫碱化合物,即(E)-2-(((4-溴苯基)亚氨基)甲基)-4-甲基苯酚(1)、(E)-2-(((3-氟苯基)亚氨基)甲基)-4-甲基苯酚(2)和(2E,2E)-2-(2-(2-羟基-5-甲基苯亚甲基)腙基)-1,2-二苯乙酮(3),产率高。通过现代技术,如 UV、FTIR 和 NMR 对合成的化合物进行了表征,而单晶 X 射线衍射技术则精确地描绘了化合物的结构,揭示了化合物 1 是正交的,而 2 和 3 是单斜的。采用混合函数(B3LYP)方法和通用基组 6-31G(d,p)对合成的席夫碱进行了优化。通过 Hirshfeld 表面分析(HS)研究了化合物晶体组装中分子间接触的贡献。为了检查合成化合物对自由基和酶抑制的能力,使用体外模型评估了自由基清除和酶抑制潜力,结果表明化合物 3 表现出最高的潜力(57.43±1.0%;DPPH、75.09±1.0%;AChE 和 64.47±1.0%;BChE)。ADMET 评估表明合成化合物具有类药性。从结果(体外和计算)推断,合成化合物具有治疗与自由基和酶抑制相关的疾病的能力。与其他化合物相比,化合物 3 表现出最强的活性。